Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 16, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

APTIMA assay approved for HIV testing

Rochelle P Walensky

    AIDS Clinical Care
    |January 19, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 10, 2014

    Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
    08:33

    Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

    Published on: January 19, 2015

    Related Experiment Videos

    Last Updated: Jun 16, 2026

    Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
    13:47

    Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

    Published on: June 23, 2011

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 10, 2014

    Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
    08:33

    Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

    Published on: January 19, 2015

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Financing Medical School in a Changing Policy Landscape: Consequences for Students and the Physician Pathway.

    Annals of internal medicine·2026
    Same author

    Hepatitis B Vaccination at Birth: Safety, Effectiveness, and Public Health Benefit.

    Pediatrics·2026
    Same author

    Cigarette smoking in PrEP recipients: a challenge and an opportunity.

    The lancet. HIV·2026
    Same author

    Navigating Conflicting Vaccination Recommendations: Guidance for Clinicians.

    JAMA·2026
    Same author

    Public Health Alerts - A New Section in <i>NEJM Evidence</i>, in Partnership with CIDRAP.

    NEJM evidence·2025
    Same author

    From Crisis to Action - Policy Pathways to Reverse the Rise in Congenital Syphilis.

    The New England journal of medicine·2025
    Same journal

    Report from the 2008 joint ICAAC/IDSA meeting. Bevirimat: predictors of response.

    AIDS clinical care·2009
    Same journal

    Report from the 2008 joint ICAAC/IDSA meeting. Maraviroc vs. efavirenz: a reanalysis of MERIT.

    AIDS clinical care·2009
    Same journal

    Report from the 2008 joint ICAAC/IDSA meeting. More on raltegravir: resistance and mechanisms of action.

    AIDS clinical care·2009
    Same journal

    Report from the 2008 joint ICAAC/IDSA meeting. Raltegravir vs. efavirenz in treatment-naive patients.

    AIDS clinical care·2009
    Same journal

    A single case of cure?

    AIDS clinical care·2009
    Same journal

    Darunavir now approved for use in treatment-naive patients.

    AIDS clinical care·2009
    See all related articles